1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 23 FEBRUARY 2015

Cancer Drug News 23 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - New ACA Initiative To Be Tested To Manage Rising Cancer Costs And Improve Cancer Care
Industry Brief - Eagle Licenses Teva To Commercialise Bendamustine Rapid Infusion In US
Industry Brief - Imbruvica Shows Efficacy/Tolerability In Heavily Treated CLL Patients Following Allo-HCT
Industry Brief - Revlimid Gains EU Approval For Newly Diagnosed MM Patients Ineligible For Transplant
Industry Brief - Seattle Genetics Submits Adcetris sBLA For Post-Transplant HL
Industry Brief - FDA Expands Indication for Revlimid/Dexamethasone Combination
Industry Brief - Dako/Ono To Co-Develop PD-1 Companion Diagnostic For Opdivo
Industry Trend Analysis - Motesanib Likely To Be Shelved After Another Phase III Failure
Industry Brief - Merrimack Initiates Biomarker-Selected MM-121 Phase II Trial
Industry Brief - FDA Grants Another ODD To Ignyta's Entrectinib
Industry Brief - Oncolytics Completes Enrolment In Reolysin Phase II Study For MCRC
Industry Brief - FDA Accepts Taiho's TAS-102 NDA For Review In Refractory MCRC
Industry Brief - Oncolytics' Reolysin Granted ODD For Pancreatic Cancer
Industry Brief - Bexion Gains FDA ODD For Saposin C To Treat Glioblastoma Multiforme
Industry Brief - Health Canada Approves NW Bio's Phase III Trial Of DCVax-L In GBM Brain Cancer
Industry Brief - FDA Grants Priority Review For Cobimetinib/Zelboraf Combination In Advanced Melanoma
Industry Brief - Patrys Granted European Patent Covering PAT-SM6
Industry Trend Analysis - No Long-Term Solution To Increasing Cancer Burden Offered In UK Election Run-Up
Industry Brief - OncoSec/Heat Biologics To Evaluate ImmunoPulse/ImPACT Immunotherapy Platforms
Industry Trend Analysis - BMS Making Waves In Future Of Onco-Immunotherapy With Two Transactions
Industry Brief - Genmab/BioNovion Enter DuoBody Technology Collaboration In Immuno-Oncology
Industry Brief - Fresenius Sells German Subsidiary To NewCo Pharma
Industry Brief - Advaxis Raises Funds To Develop Cancer Immunotherapy Pipeline

Table Of Contents

Cancer Drug News 23 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.